At a glance
What are antimicrobial peptides?
They are small proteins that help the body control microbes, especially at surfaces such as the skin and gut lining.
Can vitamin D directly influence these proteins?
Yes. Its active form can directly regulate the gene for a human defence protein called cathelicidin.
Does this make vitamin D a treatment for infection?
No. A molecular effect does not by itself show that supplements prevent or treat infections in people.
Read the full article below ↓How vitamin D relates to the body’s natural microbe-fighting molecules
Vitamin D and Antimicrobial Peptides looks at how vitamin D participates in the biology of the body’s natural defence molecules. Antimicrobial peptides are short proteins that can directly disrupt bacteria, viruses, and fungi. They are part of rapid, non-specific immune defence, especially at barrier surfaces such as skin and mucosa. Vitamin D contributes to signalling and regulatory pathways linked with their production and function.
The biological relationships described here do not establish a universal benefit from additional vitamin D. Findings in experimental systems must be distinguished from demonstrated outcomes in people. Source for this clarification.
What antimicrobial peptides do
Antimicrobial peptides help protect the body in several ways. They are involved in:
• rapid defence against a wide range of microbes
• disruption of microbial membranes
• signalling to immune cells
• shaping the local immune environment
They act early, often before highly specific adaptive immune responses are activated.
Vitamin D within antimicrobial-peptide biology
Vitamin D relates to antimicrobial peptides through several biological pathways, including:
• receptors in epithelial and immune cells
• modulation of genes that code for antimicrobial peptides
• links with innate immune activation
• interactions with mucosal and barrier tissues
Its role is regulatory and contextual rather than therapeutic, consistent with broader themes in Vitamin D and Immune Modulation.
Barrier surfaces and antimicrobial peptides
Antimicrobial peptides are particularly important at barrier surfaces, including:
• skin
• respiratory passages
• gastrointestinal tract
• other mucosal surfaces
Vitamin D is present in signalling environments at these sites and appears in discussions of Vitamin D and Mucosal Defence and Vitamin D and Barrier Immunity.
Gene expression and regulation
Production of antimicrobial peptides is controlled mainly at the genetic level. Vitamin D participates in:
• modulation of antimicrobial-peptide gene transcription
• coordination with pattern-recognition receptor signalling
• integration with inflammatory and immune pathways
These mechanisms connect vitamin D with molecular control of immune defence.
Examples of antimicrobial peptides
Key families of antimicrobial peptides include:
• cathelicidins
• defensins
• related peptide groups across tissues
Vitamin D is found within signalling contexts where these peptides are regulated and expressed.
Interaction with innate immunity
Antimicrobial peptides are part of innate immune defence, acting quickly and broadly. Vitamin D contributes to wider contexts involving:
• early immune activation
• recruitment of immune cells to barrier sites
• crosstalk between epithelial and immune cells
This illustrates their role in front-line immunity and links with Vitamin D and Inflammatory Signalling.
Role in immune communication
Antimicrobial peptides do more than directly attack microbes. They also act as communication molecules. Vitamin D participates in pathways related to:
• immune-cell chemotaxis
• modulation of inflammatory signalling
• transition from defence toward repair
They therefore influence both microbial defence and immune regulation.
Environmental and lifestyle influences
Activity of antimicrobial-peptide systems is shaped by:
• sunlight-exposure patterns
• sleep and circadian rhythm
• microbial and environmental exposures
• nutritional context
Vitamin D biology overlaps with many of these same influences and is discussed further in Vitamin D and Circadian Biology.
Life-stage considerations
Antimicrobial-peptide systems vary across the lifespan. Vitamin D’s involvement exists within:
• development of immune barriers in infancy
• adaptation through adolescence and adulthood
• age-related changes in immune defence
Context therefore changes with age, relating to pages such as Vitamin D in Infancy and Vitamin D in Older Adults.
Individual variation
The relationship between vitamin D and antimicrobial peptides varies between individuals because of:
• genetic differences in receptors and enzymes
• lifestyle and environmental exposures
• nutritional status and overall physiology
This emphasises that responses are individual rather than uniform and connects with Vitamin D Differences.
Part of rapid immune defence
Antimicrobial peptides provide fast, non-specific protection at body surfaces. Vitamin D is one contributor to the systems that regulate their production and function, linking barrier integrity, innate immunity, immune communication, and early defence.
Role in epithelial repair and renewal
Antimicrobial peptides do not operate in isolation from tissue maintenance. Barrier surfaces are constantly exposed to friction, microbes, and environmental stress, which means repair and renewal must occur continuously. Vitamin D participates in signalling environments that support epithelial turnover and recovery, creating conditions in which antimicrobial peptides can be produced and deployed effectively. This relationship overlaps with tissue repair processes at immune barriers, where immune defence and regeneration operate as a coordinated system rather than separate functions.
When epithelial integrity is compromised, antimicrobial peptides often increase locally as part of a protective response. Vitamin D’s regulatory involvement helps maintain balance between repair, defence, and controlled inflammation, supporting barrier resilience rather than unchecked immune escalation.
Coordination with inflammatory resolution
Antimicrobial peptides are most effective when inflammatory signalling is proportional and time-limited. Persistent inflammation can disrupt peptide production, alter barrier integrity, and change immune-cell behaviour. Vitamin D participates in regulatory pathways that influence how inflammatory responses resolve after microbial threat has passed. This connects antimicrobial-peptide activity with resolution of immune activation rather than continuous immune stimulation.
By shaping the signalling environment in which peptides are produced, vitamin D helps support the transition from active defence toward tissue stabilisation. This reinforces the idea that antimicrobial peptides function best within regulated immune contexts rather than prolonged inflammatory states.
Interaction with immune tolerance at barrier sites
Barrier surfaces must distinguish between harmful microbes and harmless exposures. Antimicrobial peptides contribute to this discrimination by acting locally while avoiding widespread immune activation. Vitamin D participates in regulatory environments that influence this balance, linking antimicrobial defence with immune tolerance. These processes relate to immune tolerance at environmental interfaces.
This tolerance: defence balance is particularly important in the gut and respiratory tract, where constant exposure to antigens requires restraint as well as protection. Vitamin D’s involvement supports antimicrobial activity without promoting unnecessary immune escalation.
Influence of metabolic state on peptide activity
Antimicrobial-peptide production is influenced by cellular energy availability, oxidative balance, and metabolic signalling. Vitamin D participates in pathways that link immune defence with metabolic context, helping explain why immune function often shifts during illness, stress, or metabolic imbalance. These relationships connect antimicrobial peptides with metabolic regulation of immune activity.
Cells producing antimicrobial peptides must adapt to changing energy demands. Vitamin D contributes to signalling environments that help maintain functional peptide production even when metabolic conditions fluctuate.
Microbial balance and surface ecosystems
Antimicrobial peptides help regulate microbial populations rather than sterilising barrier surfaces. A balanced microbial environment supports immune stability and tissue health. Vitamin D participates indirectly in shaping these microbial ecosystems by influencing peptide expression and barrier signalling. This perspective aligns with regulation of microbial interactions at barriers.
Rather than eliminating all microbes, antimicrobial peptides help maintain equilibrium between host and environment. Vitamin D’s regulatory role supports this balance, reinforcing long-term barrier stability.
Stress, circadian rhythm, and peptide expression
Antimicrobial-peptide expression fluctuates with circadian rhythms, stress hormones, and sleep patterns. Vitamin D biology overlaps with these same regulatory systems, helping coordinate immune readiness with daily physiological cycles. This connection is consistent with circadian regulation of immune defence.
Disruption of sleep or circadian rhythm can alter peptide production at barrier surfaces. Vitamin D’s involvement in these regulatory environments helps explain why immune defence varies across time rather than remaining constant.
Developmental establishment of antimicrobial defence
Antimicrobial-peptide systems are shaped early in life as barrier tissues mature and immune signalling networks develop. Vitamin D participates in these developmental contexts, influencing how early-life immune environments are established and maintained. These processes connect with early-life immune development.
The foundations laid during early development can influence antimicrobial responsiveness later in life, highlighting the long-term nature of immune-barrier regulation.
Long-term resilience of front-line immunity
Antimicrobial peptides contribute to immune resilience by providing rapid, adaptable defence at the body’s boundaries. Active vitamin D can directly regulate the gene for the human antimicrobial peptide cathelicidin. This molecular action does not by itself demonstrate that supplements prevent or treat infections. The clinical significance depends on the setting and cannot be inferred from gene regulation alone.
Viewed in this way, antimicrobial peptides and vitamin D together contribute to stability rather than aggression in immune defence. Their interaction helps preserve barrier integrity, microbial balance, and proportional immune responses over time.
Related reading
Potential role of salivary vitamin D antimicrobial peptide LL-37 and interleukins in severity of dental caries: an exvivo study
Therefore, in the present study we have evaluated the association of salivary vitamin D, LL-37, interleukins 6 and 17A in various levels of severity of dental caries.
Original paper ↗Read more →Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
One of the most promising therapeutic approaches for numerous hematological malignancies represents the allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Original paper ↗Read more →Vitamin D boosts HIV-1 resistance in female genital epithelial cells by enhancing antiviral cathelicidin expression
This study aimed to investigate the potential antiviral role of VitD in the female genital epithelium, which constitutes the first physical barrier against HIV-1.
Original paper ↗Read more →Vitamin D in Early Childhood and the Effect on Immunity to Mycobacterium tuberculosis
As early as birth a child is often deficient in vitamin D, which may not only affect their bone metabolism but also modulate their immune function, contributing to the increased susceptibility to many infections seen early in life.
Original paper ↗Read more →A Cross Sectional Analysis of the Role of the Antimicrobial Peptide Cathelicidin in Lung Function Impairment within the ALIVE Cohort
In a cross-sectional analysis of 650 participants in an urban observational cohort with high smoking prevalence, plasma 25(OH)-vitamin D and cathelicidin levels were measured from stored samples obtained within 6 months of spirometry study visits.
Original paper ↗Read more →Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus
The aim of this study was to investigate AMP expression in the upper gastrointestinal tract in normal and pathological metabolic states in humans.
Original paper ↗Read more →Bile acid metabolites enhance expression of cathelicidin antimicrobial peptide in airway epithelium through activation of the TGR5-ERK1/2 pathway
Signals for the maintenance of epithelial homeostasis are provided in part by commensal bacteria metabolites, that promote tissue homeostasis in the gut and remote organs as microbiota metabolites enter the bloodstream.
Original paper ↗Read more →Calcitriol stimulates gene expression of cathelicidin antimicrobial peptide in breast cancer cells with different phenotype
Tumorigenicity was evaluated for each cell line in athymic mice.
Original paper ↗Read more →Emerging Roles of Vitamin D-Induced Antimicrobial Peptides in Antiviral Innate Immunity
Vitamin D deficiency, characterized by low circulating levels of calcifediol (25-hydroxyvitamin D, 25D) has been linked to increased risk of infections of bacterial and viral origin.
Original paper ↗Read more →Human Metapneumovirus Infection Inhibits Cathelicidin Antimicrobial Peptide Expression in Human Macrophages
Human cathelicidin antimicriobial peptide (CAMP) is a critical component of host innate immunity with both antimicrobial and immunomodulatory functions.
Original paper ↗Read more →Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 Treatment
In this study we investigated whether antimicrobial peptide levels in nasal secretions of allergic asthma patients are lower than in healthy controls, and whether administration of the active form of vitamin D (1,25(OH)2D3) affects these antimicrobial peptide levels.
Original paper ↗Read more →Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
Transcription of the cathelicidin antimicrobial peptide (CAMP) gene is induced by binding of the bioactive form of vitamin D, 1,25-dihydroxyvitamin D, to the vitamin D receptor.
Original paper ↗Read more →Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis
The aim of the present study was to analyze the status and correlations of vitamin D, LL-37 and Th-associated cytokines in patients with PTB or PTB with DM (DMPTB).
Original paper ↗Read more →Vitamin A: and D-Deficient Diets Disrupt Intestinal Antimicrobial Peptide Defense Involving Wnt and STAT5 Signaling Pathways in Mice
VAd mice compared to CD mice showed a reduced villus length in the ileum (p < 0.01) and decreased crypt depth in the colon (p < 0.05).
Original paper ↗Read more →Vitamin D Analogs Differentially Control Antimicrobial Peptide/“Alarmin”Expression in Psoriasis
Antimicrobial peptides (AMPs) are strongly expressed in lesional skin in psoriasis and play an important role as proinflammatory “alarmins” in this chronic skin disease.
Original paper ↗Read more →Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder
The urinary tract is frequently being exposed to potential pathogens and rapid defence mechanisms are therefore needed.
Original paper ↗Read more →Vitamin D nutritional status and vitamin D regulated antimicrobial peptides in serum and pleural fluid of patients with infectious and noninfectious pleural effusions
The levels of 25 OH-vitamin D, 1,25-(OH)2-vitamin D, Vitamin D Binding Protein (VDBP), LL-37 and β-defensin 2, both in serum and pleural fluid were evaluated in this prospective study.
Original paper ↗Read more →The Cooperation of Bifidobacterium longum and Active Vitamin D3 on Innate Immunity in Salmonella Colitis Mice via Vitamin D Receptor
Hence, we investigated the synergistic effects of probiotics and active vitamin D on Salmonella colitis and translocation to liver and spleen by in vitro and in vivo studies.
Original paper ↗Read more →Vitamin D and Innate Immunity
Innate immunity is the body’s first line of defence.
Read more →Vitamin D Roles Across Developmental Stages in Pediatric Pneumonia: Linking Genetics, Microbiome, Maternal Status and Immunity
Peer‐reviewed articles, including observational studies, randomized controlled trials, and reviews, were screened.
Original paper ↗Read more →Zika virus infection suppresses CYP24A1 and CAMP expression in human monocytes
We investigated the relationship between ZIKV infection and the expression of genes of the VitD3 pathway, as well as the inflammatory response of infected monocytes in vitro.
Original paper ↗Read more →Original sources
Source for this clarification
The biological relationships described here do not establish a universal benefit from additional vitamin D.
Publication details
The biological relationships described here do not establish a universal benefit from additional vitamin D. Findings in experimental systems must be distinguished from demonstrated outcomes in people. Source for this clarification.